Inspire Medical Systems (INSP) Cost of Revenue (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Cost of Revenue data on file, last reported at $27.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 9.89% year-over-year to $27.7 million; the trailing twelve-month figure through Mar 2026 stood at $130.2 million (up 0.97% YoY), and the FY2025 full-year result was $133.2 million, up 8.33% from the prior year.
• Cost of Revenue fell to $27.7 million in Q1 2026, from $36.1 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $36.1 million in Q4 2025 to a low of $10.0 million in Q1 2022.
• A 5-year average of $26.3 million and a median of $27.7 million in 2026 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue jumped 129.43% in 2022 and declined 9.89% in 2026, its largest moves.
• Tracing INSP's Cost of Revenue over 5 years: stood at $22.2 million in 2022, then increased by 26.64% to $28.1 million in 2023, then rose by 28.28% to $36.0 million in 2024, then rose by 0.23% to $36.1 million in 2025, then fell by 23.29% to $27.7 million in 2026.
• Business Quant data shows INSP's Cost of Revenue at $27.7 million in Q1 2026, $36.1 million in Q4 2025, and $31.8 million in Q3 2025.